Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewMSD becomes a healthcare partner of the Women's National Football Team
The aim of this alliance is to promote social awareness of human papillomavirus, the most common sexually transmitted infection that can cause various types of cancer, including cervical cancer.
-
-
NewORYZON receives European Medicines Agency approval to initiate a Phase II study of iadadem...
Essential thrombocythemia is the most common type of myeloproliferative neoplasm (MPN) and is associated with an increased risk of serious complications such as stroke, heart attack, and pulmonary
-
CompanyPHOENIX BIOSOLUTIONS
-
NewThe impact of digital twins on personalised medicine
Digital twins make it possible to simulate personalised clinical scenarios without intervening directly on the patient, reducing uncertainty in decision-making.
-
NewORYZON to participate in upcoming events in February and March
Oryzon Genomics will be attending Bio-Neuroscience 2026, SmallCap Event 20th Edition, BIO-Europe Spring 2026 and LSX World Congress Europe.
-
CompanyMOLDRUG AI SYSTEMS
-
-
NewPharmacelera raises €6 million to expand in U.S. and build out its high speed, high accura...
The investment round was led by investment fund manager Heran Partners, with participation from Clave Capital, Inveready, and Bio&Tech Smart Capital.
-
New#NewAseBioMember | “AseBio is much more than an association: it’s a living ecosystem that ...
Meet Medhionine, our new member. We spoke with Carmen Jiménez Medina, CEO.
-
Eventbio:cap 2026
-
NewNatac presents its National Awards for Research in Natural Products
These awards recognize scientific excellence in the field of natural products and their applications for health and well-being
-
NewVytenis Andriukaitis and Wouter Beke will lead the debate on the Biotech Act in the Europe...
We consider these appointments to be key to driving this historic process forward, as it will establish the rules governing European biotechnological innovation over the next two decades and lay the
-
NewKlinea strengthens its growth in the cosmetics industry through a strategic alliance with ...
The incorporation of advanced biotechnological assets—such as proteins, peptides, fermented products, or cell derivatives—adds the challenge of ensuring their robust and reliable manufacture, scaling
-
NewBIOSPAIN 2026 launches its website and opens registration for the next edition in Bilbao
Don’t miss the opportunity to secure the best exhibition spaces, explore sponsorship options for maximum visibility, and register to attend one of Europe’s key industry gatherings, offering unique
-
-
NewChildhood Cancer Needs Greater Awareness and Stable Funding to Accelerate Innovative Thera...
Marina Salmón, Head of Project Evaluation at the Scientific Foundation of the Spanish Association Against Cancer, a partner of AseBio, analyzes the situation on International Childhood Cancer Day.
-
Press releaseChildhood Cancer Needs Greater Awareness and Stable Funding to Accelerate Innovative Thera...
In Spain, around 1,500 cases of childhood cancer are diagnosed each year (1% of the total), making research more challenging and requiring cooperation among multiple centers, including internationally
-
NewGyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy for acute ...
The study has been initiated at Hospital La Fe in Valencia and Hospital Clínic Barcelona, two internationally recognized refence centers for acute leukemias and advanced therapies.
-
NewORYZON announces appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer...
Based in New Jersey (USA), to lead ORYZON’s CNS clinical development.
-
NewMore Women in Science: Biotechnology as a Driving Force to Close the Gender Gap
AseBio and the Biotech Platform are launching the fourth edition of “A Day with a Biotech Woman”, enabling young women—the emerging talent of today—to experience and closely follow the work of a
